tenidap has been researched along with Acute Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bliven, ML; Eskra, JD; Otterness, IG | 1 |
Egido, J; Gutierrez, S; Hernandez, P; Herrero-Beaumont, G; Lopez-Armada, MJ; Martinez, J; Miguelez, R; Palacios, I; Sanchez-Pernaute, O | 1 |
2 other study(ies) available for tenidap and Acute Disease
Article | Year |
---|---|
Limitation of activity in an acute model of arthritis: effect of drug treatment.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Chromatography, High Pressure Liquid; Cricetinae; Disease Models, Animal; Female; Indoles; Indomethacin; Injections, Intra-Articular; Mesocricetus; Motor Activity; Oxindoles; Piroxicam | 1997 |
Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens; Arthritis, Experimental; Cells, Cultured; Chemokine CCL2; Chemokines; Cyclooxygenase Inhibitors; Disease Models, Animal; Down-Regulation; Gene Expression; Indoles; Interleukin-8; Leukocytes; Oxindoles; Rabbits; RNA, Messenger; Synovial Membrane; Tumor Necrosis Factor-alpha | 1998 |